NEW YORK (TheStreet) -- CHANGE IN RATINGS

Apple

(AAPL) - Get Report

initiated at Calyon Securities with a Buy rating and $260 price target. Analysts mentioned the much-anticipated potential launch of a tablet product in 2010, and further market share gains for iPhone, esp in China.

Baidu

(BIDU) - Get Report

rated new Hold at Kaufman. Valuation call, based on a $470 price target. Stock will remain in a trading range, following the Phoenix Nest purchase.

Endo Pharmaceuticals

(ENDP) - Get Report

downgraded at Barclays to Equal Weight from Overweight. Price target plunged to $20 from $29. 2009 EPS estimate maintained at $2.73, 2010 lowered to $2.76.

Forest Oil

(FST) - Get Report

upgraded at Morgan Stanley from Underweight to Equal-weight. Asset sale addresses important funding issues.

Itron

(ITRI) - Get Report

initiated at BofA/Merrill with a Buy rating and $72 price target as the company is a leader in the emerging smart grid theme. 2009 and 2010 EPS estimates set at $1.89 and $3.19, respectively.

JA Solar

(JASO)

upgraded at Thomas Weisel to Market Weight from Underweight on improved market conditions. Price target raised by a dollar to $4. 2009 and 2010 EPS estimates set a $0.08 and $0.25, respectively.

Motorola

( MOT) initiated at Bernstein with an Outperform rating and $11 price target. Analysts said MOT appears undervalued, and credible break-up scenarios exist and could materialize in 2010. 2009 and 2010 EPS estimates set at $0.01 and $0.33, respectively.

M&T Bank

(MTB) - Get Report

upgraded at Suntrust from Neutral to Buy. $85 price target. Credit losses should be manageable over the remainder of the cycle.

Sprint Nextel

(S) - Get Report

downgraded at Pali from Buy to Neutral. Subscriber losses are not improving enough to boost EBITDA.

Suntech Power

(STP)

upgraded at Thomas Weisel to Market Weight from Underweight. Price target boosted to $14 from $12. 2009 and 2010 EPS estimates set at $0.41 and $0.80, respectively.

Sysco

(SYY) - Get Report

upgraded at Citigroup from Hold to Buy. $34 price target. Recent industry checks show modest improvement.

Dentsply

(XRAY) - Get Report

rated new Outperform at William Blair. Company can generate double-digit earnings growth and take market share.

STOCK COMMENTS / EPS CHANGES

Accenture

(ACN) - Get Report

estimates, target boosted at Goldman. Estimates were increased through 2012. Company is seeing a faster recovery in spending. Buy rating and new $50 price target.

TST Recommends

AIG

(AIG) - Get Report

estimates, target lowered at UBS. Shares now seen reaching $32. Estimates were also cut, to reflect weak P&C operating trends. Neutral rating.

Akamai

(AKAM) - Get Report

numbers increased at Goldman. Shares of AKAM now seen reaching $21.50. Estimates also raised, to match the company's new guidance for higher traffic. Sell rating.

Ciena

(CIEN) - Get Report

price target raised, estimates changed at Credit Suisse to $14.50 from $11. 2009 EPS estimate raised to -$0.85, 2010 lowered to -$1.30.

Dana Holding

(DAN) - Get Report

target, estimates higher at Barclays. DAN price target raised to $12 from $8 on strong 2010 guidance expectations. 2009 and 2010 EPS estimates raised to -$0.79 and $0.45, respectively. Maintain Overweight rating.

Denbury Resources

(DNR) - Get Report

price target increased at Credit Suisse to $15. 2009 EPS estimate introduced at $0.71, 2010 raised to $0.36. Neutral rating.

Edwards Lifesciences

(EW) - Get Report

estimates raised at Morgan Stanley through 2011. Favorable reimbursement rates should drive procedure growth in Germany and the company is positioned well to gain market share. Equal-weight rating.

FedEx

(FDX) - Get Report

price target higher at BofA/Merrill to $100 as the company preannounces F2Q10 above well consensus, at $1.10. Maintain Buy rating.

FedEx

(FDX) - Get Report

numbers boosted at JP Morgan. Shares now seen reaching $110. Estimates also raised, to reflect the company's new volume guidance and strong operating leverage.

FedEx

(FDX) - Get Report

target, estimates boosted at Credit Suisse. Price target to $89 from $82. 2010 and 2011 EPS estimates lifted to $3.60 and $4.50, respectively. Neutral rating.

Hanesbrands

(HBI) - Get Report

target higher, estimates mixed at Credit Suisse. HBI price target boosted to $33 from $29. 2009 EPS estimate dropped to $1.70, 2010 introduced at $2.20. Reiterate Outperform rating.

MetLife

(MET) - Get Report

estimates raised at FBR through 2011. Company seeing higher investment income and better margins in the U.S. Market Perform rating and $41 price target.

MetLife

(MET) - Get Report

estimates changed at Barclays. MET 2009 EPS estimate dropped to $2.84, 2010 raised to $4.16. Maintain Overweight rating and $42 price target.

NY Community Bancorp

( NYB) numbers raised at Morgan Stanley through 2011. Amtrust purchase should add to earnings. Equal-weight rating and new $13 price target.

This article was written by a staff member of TheStreet.com.